Consolidated Condensed Statements of Stockholders’ Deficit (Unaudited) - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Oct. 31, 2022		979,869,000
Balance at beginning of period at Oct. 31, 2022	$ (3,025)	$ 10	$ 1,172	$ (4,492)	$ 285
Increase (Decrease) in Stockholders' Equity
Net earnings	469			469
Other comprehensive income (loss), net of taxes	(741)				(741)
Comprehensive income	(272)
Issuance of common stock in connection with employee stock plans and other (in shares)		8,844,000
Issuance of common stock in connection with employee stock plans and other	(79)		(79)
Repurchases of common stock (in shares)		(3,624,000)
Repurchases of common stock (Note 10)	(100)		(4)	(96)
Cash dividends	(518)			(518)
Stock-based compensation expense	167		167
Balance (in shares) at Jan. 31, 2023		985,089,000
Balance at end of period at Jan. 31, 2023	(3,827)	$ 10	1,256	(4,637)	(456)
Balance (in shares) at Oct. 31, 2022		979,869,000
Balance at beginning of period at Oct. 31, 2022	(3,025)	$ 10	1,172	(4,492)	285
Increase (Decrease) in Stockholders' Equity
Net earnings	2,289
Other comprehensive income (loss), net of taxes	(639)
Comprehensive income	$ 1,650
Repurchases of common stock (in shares)	(3,600,000)
Balance (in shares) at Jul. 31, 2023		988,220,000
Balance at end of period at Jul. 31, 2023	$ (2,245)	$ 10	1,435	(3,336)	(354)
Balance (in shares) at Jan. 31, 2023		985,089,000
Balance at beginning of period at Jan. 31, 2023	(3,827)	$ 10	1,256	(4,637)	(456)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,054			1,054
Other comprehensive income (loss), net of taxes	88				88
Comprehensive income	1,142
Issuance of common stock in connection with employee stock plans and other (in shares)		787,000
Issuance of common stock in connection with employee stock plans and other	(7)		(7)
Cash dividends	4			4
Stock-based compensation expense	95		95
Balance (in shares) at Apr. 30, 2023		985,876,000
Balance at end of period at Apr. 30, 2023	(2,593)	$ 10	1,344	(3,579)	(368)
Increase (Decrease) in Stockholders' Equity
Net earnings	766			766
Other comprehensive income (loss), net of taxes	14				14
Comprehensive income	$ 780
Issuance of common stock in connection with employee stock plans and other (in shares)		2,344,000
Repurchases of common stock (in shares)	0
Cash dividends	$ (523)			(523)
Stock-based compensation expense	91		91
Balance (in shares) at Jul. 31, 2023		988,220,000
Balance at end of period at Jul. 31, 2023	$ (2,245)	$ 10	1,435	(3,336)	(354)
Balance (in shares) at Oct. 31, 2023	989,000,000	988,782,000
Balance at beginning of period at Oct. 31, 2023	$ (1,069)	$ 10	1,505	(2,361)	(223)
Increase (Decrease) in Stockholders' Equity
Net earnings	622			622
Other comprehensive income (loss), net of taxes	(235)				(235)
Comprehensive income	387
Issuance of common stock in connection with employee stock plans and other (in shares)		8,677,000
Issuance of common stock in connection with employee stock plans and other	(76)		(76)
Repurchases of common stock (in shares)		(17,062,000)
Repurchases of common stock (Note 10)	(514)		(27)	(487)
Cash dividends	(545)			(545)
Stock-based compensation expense	177		177
Balance (in shares) at Jan. 31, 2024		980,397,000
Balance at end of period at Jan. 31, 2024	$ (1,640)	$ 10	1,579	(2,771)	(458)
Balance (in shares) at Oct. 31, 2023	989,000,000	988,782,000
Balance at beginning of period at Oct. 31, 2023	$ (1,069)	$ 10	1,505	(2,361)	(223)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,869
Other comprehensive income (loss), net of taxes	(192)
Comprehensive income	$ 1,677
Repurchases of common stock (in shares)	(37,500,000)
Balance (in shares) at Jul. 31, 2024	963,000,000	963,408,000
Balance at end of period at Jul. 31, 2024	$ (1,392)	$ 10	1,742	(2,729)	(415)
Balance (in shares) at Jan. 31, 2024		980,397,000
Balance at beginning of period at Jan. 31, 2024	(1,640)	$ 10	1,579	(2,771)	(458)
Increase (Decrease) in Stockholders' Equity
Net earnings	607			607
Other comprehensive income (loss), net of taxes	126				126
Comprehensive income	733
Issuance of common stock in connection with employee stock plans and other (in shares)		584,000
Issuance of common stock in connection with employee stock plans and other	(4)		(4)
Repurchases of common stock (in shares)		(3,474,000)
Repurchases of common stock (Note 10)	(99)		(6)	(93)
Stock-based compensation expense	94		94
Balance (in shares) at Apr. 30, 2024		977,507,000
Balance at end of period at Apr. 30, 2024	(916)	$ 10	1,663	(2,257)	(332)
Increase (Decrease) in Stockholders' Equity
Net earnings	640			640
Other comprehensive income (loss), net of taxes	(83)				(83)
Comprehensive income	557
Issuance of common stock in connection with employee stock plans and other (in shares)		2,907,000
Issuance of common stock in connection with employee stock plans and other	$ 13		13
Repurchases of common stock (in shares)	(17,000,000.0)	(17,006,000)
Repurchases of common stock (Note 10)	$ (606)		(30)	(576)
Cash dividends	(536)			(536)
Stock-based compensation expense	$ 96		96
Balance (in shares) at Jul. 31, 2024	963,000,000	963,408,000
Balance at end of period at Jul. 31, 2024	$ (1,392)	$ 10	$ 1,742	$ (2,729)	$ (415)